On Nov 01, major Wall Street analysts update their ratings for $Merit Medical Systems (MMSI.US)$, with price targets ranging from $109 to $125.
Baird analyst David Rescott maintains with a buy rating, and adjusts the target price from $96 to $109.
Needham analyst Michael Matson maintains with a buy rating, and maintains the target price at $109.
Piper Sandler analyst Jason Bednar maintains with a buy rating, and maintains the target price at $110.
CCORF analyst John Young CFA maintains with a buy rating, and maintains the target price at $125.
Barrington analyst Michael Petusky maintains with a buy rating, and maintains the target price at $114.
Furthermore, according to the comprehensive report, the opinions of $Merit Medical Systems (MMSI.US)$'s main analysts recently are as follows:
Merit Medical has delivered another beat and raise, with nearly 6% organic revenue growth and 180 basis points of operating margin expansion. The upcoming WRAPSODY launch is anticipated to be a key growth driver and could potentially accelerate growth over the next several years.
Here are the latest investment ratings and price targets for $Merit Medical Systems (MMSI.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
